Yıl: 2022 Cilt: 39 Sayı: 3 Sayfa Aralığı: 138 - 145 Metin Dili: İngilizce DOI: 10.4103/nsn.nsn_117_21 İndeks Tarihi: 03-05-2023

Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients

Öz:
Purpose: The purpose of the study is to analyze the neurological manifestations and to determine the association between these symptoms and mortality in hospitalized patients with coronavirus disease 2019 (COVID 19). Materials and Methods: Five hundred and forty seven hospitalized patients with positive reverse transcriptase polymerase chain reaction tests for severe acute respiratory syndrome coronavirus in a nasopharyngeal swab were included in this study. The demographic features, laboratory data, and radiologic imaging, neurological symptoms of hospitalized patients with COVID 19 were collected. Results: Of 547 hospitalized COVID 19 patients, the median age was 61 (range 18–93), 61.4% were male. Three hundred and forty seven (63.4%) patients had a severe infection and 200 (36.6%) patients had a mild infection. Eighty eight patients (16.1%) died during hospitalization. One hundred and fifty four (28.2%) patients had at least one neurological symptom. Thirty five (6.4%) patients manifested with only neurological symptoms at hospital admission. The most frequent neurological symptoms were headache (15.2%), taste and smell disorders (9.1%), and myalgia (6.6%). The other initial neurological manifestations were acute cerebral ischemic stroke, impaired consciousness, epileptic seizure, and posterior reversible encephalopathy. The late onset neurological complications were autoimmune encephalitis and Guillain Barre syndrome. The neurological manifestation was linked to the severity of disease (P = 0.005) but not correlated with mortality (P = 0.137). Conclusion: Neurological symptoms were frequent in COVID 19 patients. The neurological symptoms can be the initial symptoms or can be late onset complications of COVID 19.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Taubenberger JK, Morens DM. 1918 influenza: The mother of all pandemics. Emerg Infect Dis 2006;12:15 22.
  • 2. Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS CoV 2: Structure, biology, and structure based therapeutics development. Front Cell Infect Microbiol 2020;10:587269.
  • 3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497 506.
  • 4. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS coronavirus 2. Int J Infect Dis 2020;94:55 8.
  • 5. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS CoV 2: From neurological manifestations of COVID 19 to potential neurotropic mechanisms. J Neurol 2020;267:2179 84.
  • 6. Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS CoV2 infection. Brain Behav Immun 2020;88:11 6.
  • 7. Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, et al. A systematic review of neurological symptoms and complications of COVID 19. J Neurol 2021;268:392 402.
  • 8. Romero Sánchez CM, Díaz Maroto I, Fernández Díaz E, Sánchez Larsen Á, Layos Romero A, García García J, et al. Neurologic manifestations in hospitalized patients with COVID 19: The ALBACOVID registry. Neurology 2020;95:e1060 70.
  • 9. Eskandar EN, Altschul DJ, de la Garza Ramos R, Cezayirli P, Unda SR, Benton J, et al. Neurologic syndromes predict higher in hospital mortality in COVID 19. Neurology 2021;96:e1527 38.
  • 10. Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, et al. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID 19: A multicenter prospective clinical study. BMC Neurol 2021;21:116.
  • 11. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200:e45 67.
  • 12. Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID 19. Nat Rev Neurol 2020;16:636 44.
  • 13. Bhandari R, Khanna G, Kaushik D, Kuhad A. Divulging the intricacies of crosstalk between NF Kb and Nrf2 Keap1 pathway in neurological complications of COVID 19. Mol Neurobiol 2021;58:3347 61.
  • 14. Baysal Kirac L, Uysal H. COVID 19 associate neurological complications. Neurol Sci Neurophysiol 2020;37:1.
  • 15. Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID 19. Neurol Sci 2020;41:1991 5.
  • 16. Uygun Ö, Ertaş M, Ekizoğlu E, Bolay H, Özge A, Kocasoy Orhan E, et al. Headache characteristics in COVID 19 pandemic – A survey study. J Headache Pain 2020;21:121.
  • 17. Talavera B, García Azorín D, Martínez Pías E, Trigo J, Hernández Pérez I, Valle Peñacoba G, et al. Anosmia is associated with lower in hospital mortality in COVID 19. J Neurol Sci 2020;419:117163.
  • 18. Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS CoV 2 and stroke in a New York healthcare system. Stroke 2020;51:2002 11.
  • 19. Vogrig A, Gigli GL, Bnà C, Morassi M. Stroke in patients with COVID 19: Clinical and neuroimaging characteristics. Neurosci Lett 2021;743:135564.
  • 20. Topcuoglu MA, Pektezel MY, Oge DD, Bulut Yüksel ND, Ayvacioglu C, Demirel E, et al. Stroke mechanism in COVID 19 infection: A prospective case control study. J Stroke Cerebrovasc Dis 2021;30:105919.
  • 21. Syahrul S, Maliga HA, Ilmawan M, Fahriani M, Mamada SS, Fajar JK, et al. Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: Incidence, risk factors, and pathogenesis – A systematic review and meta analysis. F1000Res 2021;10:34.
  • 22. Altschul DJ, Unda SR, de La Garza Ramos R, Zampolin R, Benton J, Holland R, et al. Hemorrhagic presentations of COVID 19: Risk factors for mortality. Clin Neurol Neurosurg 2020;198:106112.
  • 23. Beyrouti R, Best JG, Chandratheva A, Perry RJ, Werring DJ. Characteristics of intracerebral haemorrhage associated with COVID 19: A systematic review and pooled analysis of individual patient and aggregate data. J Neurol 2021;268:3105 15.
  • 24. Emami A, Fadakar N, Akbari A, Lotfi M, Farazdaghi M, Javanmardi F, et al. Seizure in patients with COVID 19. Neurol Sci 2020;41:3057 61.
  • 25. Yuksel H, Gursoy GT, Dirik EB, Kenar SG, Bektas H, Yamanel L, et al. Neurological manifestations of COVID 19 in confirmed and probable cases: A descriptive study from a large tertiary care center. J Clin Neurosci 2021;86:97 102.
  • 26. Asadi Pooya AA. Seizures associated with coronavirus infections. Seizure 2020;79:49 52.
  • 27. Abenza Abildúa MJ, Atienza S, Carvalho Monteiro G, Erro Aguirre ME, Imaz Aguayo L, Freire Álvarez E, et al. Encephalopathy and encephalitis during acute SARS CoV 2 infection. Spanish Society of Neurology COVID 19 Registry. Neurologia (Engl Ed) 2021;36:127 34.
  • 28. Pizzanelli C, Milano C, Canovetti S, Tagliaferri E, Turco F, Verdenelli S, et al. Autoimmune limbic encephalitis related to SARS CoV 2 infection: Case report and review of the literature. Brain Behav Immun Health 2021;12:100210.
  • 29. Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID 19. BMJ Case Rep 2020;13:e238419.
  • 30. Lang B, Hintze J, Conlon B. Coronavirus disease 2019 and sudden sensorineural hearing loss. J Laryngol Otol 2020;134:1026-8.
APA ÖZEL T, ŞİMŞEK ERDEM N, ÜNAL A, YALÇIN A, İNAN D, İLHANLI N, UYSAL H (2022). Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. , 138 - 145. 10.4103/nsn.nsn_117_21
Chicago ÖZEL Tuğba,ŞİMŞEK ERDEM Nazan,ÜNAL Ali,YALÇIN Ata Nevzat,İNAN DİLARA,İLHANLI Nevruz,UYSAL Hilmi Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. (2022): 138 - 145. 10.4103/nsn.nsn_117_21
MLA ÖZEL Tuğba,ŞİMŞEK ERDEM Nazan,ÜNAL Ali,YALÇIN Ata Nevzat,İNAN DİLARA,İLHANLI Nevruz,UYSAL Hilmi Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. , 2022, ss.138 - 145. 10.4103/nsn.nsn_117_21
AMA ÖZEL T,ŞİMŞEK ERDEM N,ÜNAL A,YALÇIN A,İNAN D,İLHANLI N,UYSAL H Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. . 2022; 138 - 145. 10.4103/nsn.nsn_117_21
Vancouver ÖZEL T,ŞİMŞEK ERDEM N,ÜNAL A,YALÇIN A,İNAN D,İLHANLI N,UYSAL H Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. . 2022; 138 - 145. 10.4103/nsn.nsn_117_21
IEEE ÖZEL T,ŞİMŞEK ERDEM N,ÜNAL A,YALÇIN A,İNAN D,İLHANLI N,UYSAL H "Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients." , ss.138 - 145, 2022. 10.4103/nsn.nsn_117_21
ISNAD ÖZEL, Tuğba vd. "Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients". (2022), 138-145. https://doi.org/10.4103/nsn.nsn_117_21
APA ÖZEL T, ŞİMŞEK ERDEM N, ÜNAL A, YALÇIN A, İNAN D, İLHANLI N, UYSAL H (2022). Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. Neurological sciences and neurophysiology (Online), 39(3), 138 - 145. 10.4103/nsn.nsn_117_21
Chicago ÖZEL Tuğba,ŞİMŞEK ERDEM Nazan,ÜNAL Ali,YALÇIN Ata Nevzat,İNAN DİLARA,İLHANLI Nevruz,UYSAL Hilmi Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. Neurological sciences and neurophysiology (Online) 39, no.3 (2022): 138 - 145. 10.4103/nsn.nsn_117_21
MLA ÖZEL Tuğba,ŞİMŞEK ERDEM Nazan,ÜNAL Ali,YALÇIN Ata Nevzat,İNAN DİLARA,İLHANLI Nevruz,UYSAL Hilmi Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. Neurological sciences and neurophysiology (Online), vol.39, no.3, 2022, ss.138 - 145. 10.4103/nsn.nsn_117_21
AMA ÖZEL T,ŞİMŞEK ERDEM N,ÜNAL A,YALÇIN A,İNAN D,İLHANLI N,UYSAL H Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. Neurological sciences and neurophysiology (Online). 2022; 39(3): 138 - 145. 10.4103/nsn.nsn_117_21
Vancouver ÖZEL T,ŞİMŞEK ERDEM N,ÜNAL A,YALÇIN A,İNAN D,İLHANLI N,UYSAL H Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients. Neurological sciences and neurophysiology (Online). 2022; 39(3): 138 - 145. 10.4103/nsn.nsn_117_21
IEEE ÖZEL T,ŞİMŞEK ERDEM N,ÜNAL A,YALÇIN A,İNAN D,İLHANLI N,UYSAL H "Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients." Neurological sciences and neurophysiology (Online), 39, ss.138 - 145, 2022. 10.4103/nsn.nsn_117_21
ISNAD ÖZEL, Tuğba vd. "Neurological Manifestations and Mortality in Hospitalized Coronavirus Disease 2019 Patients". Neurological sciences and neurophysiology (Online) 39/3 (2022), 138-145. https://doi.org/10.4103/nsn.nsn_117_21